VEGF is differentially regulated in multiple myeloma-derived cell lines by norepinephrine
Authors:
- 1 March 2008
- journal article
- research article
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 22 (3) , 318-323
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The small-molecule VEGF receptor inhibitor pazopanib (GW786034B) targets both tumor and endothelial cells in multiple myelomaProceedings of the National Academy of Sciences, 2006
- Norepinephrine Up-regulates the Expression of Vascular Endothelial Growth Factor, Matrix Metalloproteinase (MMP)-2, and MMP-9 in Nasopharyngeal Carcinoma Tumor CellsCancer Research, 2006
- Angiogenesis in multiple myelomaEuropean Journal of Cancer, 2006
- Stress Hormone–Mediated Invasion of Ovarian Cancer CellsClinical Cancer Research, 2006
- The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implicationsBlood, 2005
- Vascular endothelial growth factor and social support in patients with ovarian carcinomaCancer, 2002
- Chromosome translocations in multiple myelomaOncogene, 2001
- Ectopic Expression of MAFB Gene in Human Myeloma Cells Carrying (14;20)(q32;q11) Chromosomal TranslocationsJapanese Journal of Cancer Research, 2001
- Psychoneuroimmunology and cancer: fact or fiction?European Journal of Cancer, 1999
- Mouse Mammary Tumors: Alteration of Incidence as Apparent Function of StressScience, 1975